$114.61

Retatrutide Acetate is a 39-amino acid, triagonist peptide targeting the GLP-1, GIP, and glucagon receptors. Engineered for advanced metabolic research, this synthetic analog incorporates a C20 fatty diacid moiety to extend half-life via albumin binding, making it ideal for studies on obesity, glucose tolerance, and energy homeostasis. Its multifunctional receptor activity supports investigations into synergistic incretin and glucagon-based mechanisms.
Supplied as a lyophilized acetate salt, Retatrutide Acetate is optimized for sterility, structural integrity, and long-term stability. Presented in a 3mL vial, this lipidated triagonist is suited for experimental models focusing on weight regulation, hepatic fat reduction, and insulin responsiveness.
Solubility: Retatrutide Acetate is soluble in sterile water, dilute acetic acid, or aqueous buffers at pH 5–7.
For laboratory research use only. Not for human or veterinary applications.

Description

Retatrutide Acetate

Chemical Name: Retatrutide Acetate
Molecular Formula: C₂₁₀H₃₂₅N₅₃O₆₂S · xC₂H₄O₂
Molecular Weight: ~4700.27 g/mol (free base)
CAS Number: 2748043-91-4

Sequence:
H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEA-C20 fatty diacid)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-Ser-Ser-Gly-Ala-Pro-Ser-Pro-Pro-Ser-NH₂
(Lipidated triagonist peptide targeting GLP-1, GIP, and glucagon receptors)

Structural Characteristics:
Retatrutide is a long-acting synthetic triagonist peptide that simultaneously activates the GLP-1, GIP, and glucagon receptors. The sequence includes a C20 fatty acid conjugated via an AEEA linker at Lys20 to enhance albumin binding and extend plasma half-life, making it ideal for chronic metabolic research.

Mechanism of Action (Research Context):
Retatrutide supports multi-receptor incretin and glucagon pathway modulation with potential synergistic effects on:

  • Glucose metabolism and insulin sensitivity
  • Appetite suppression and energy expenditure
  • Hepatic fat reduction and body weight regulation

Synthesis and Quality Control:

  • Produced using solid-phase peptide synthesis (SPPS)
  • HPLC-purified to ≥98%
  • Verified via Mass Spectrometry (MS)

Product Details:

  • Form: Lyophilized acetate salt
  • Appearance: White to off-white powder

Solubility:
Retatrutide Acetate is soluble in sterile water, dilute acetic acid, or aqueous buffers at pH 5–7.

Storage & Handling:

  • Store lyophilized powder at –20°C, protected from light and moisture
  • After reconstitution, refrigerate at 2–8°C for up to 30 days
  • For long-term use, aliquot and freeze at –20°C
  • Avoid repeated freeze-thaw cycles

Disclaimer:
For research use only. Not intended for human or veterinary use. Not for diagnostic or therapeutic applications.

Additional information

Weight .06 lbs
Dimensions .5 × .5 × 1 in

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.